26 points by salkahfi 9 hours ago | 5 comments
- Great to see an example of concrete evidence that physicians made changes when the evidence showed a change was needed.
- This "evidence" is highly questionable. There's other evidence, i.e., that taking aspirin with DGL or vitamin C does not damage the stomach lining, have led to new formulations decades ago. In fact, high doses of aspirin have been sold in Europe combined with vitamin C for as long as I remember - Aspirin C by Bayer and Upsarin C by UPSA. There's other evidence, too, that aspirin protects against cancer.
- [dead]
- Low-dode aspirin wrecks the stomach or small intestine anyway in many individuals, irrespective of its form. This strikes a lot sooner than internal bleeding. Both the chewable and the enteric-coated forms cause this injury at separate locations.
- >in many individuals,
So then why are we not working to determine which individuals it is suitable for?
What is the alternative to aspirin for this use case and who benefits?
- It doesn't, as it doesn't dissolve in the stomach, thanks to its enteric coating.